Isocitrate dehydrogenase (IDH) mutation status was available for 35/37 patients: 31 patients were IDH wild type, while four patients (two WHO grade II glioma, two WHO grade III glioma) carried a mutant IDH allele. The gene discussed is IDH3A; the disease is glioma.